Immuneering Corporation (IMRX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 64
-0.14
-2.9289%
$
189.14M Market Cap
- P/E Ratio
- Div Yield
1.45M Volume
-1.89 Eps
$ 4.78
Previous Close 
Want to track IMRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IMRX Earnings Reports FAQ
What is the earnings per share (EPS) for IMRX?
The current EPS is -1.89.
What is the company's earnings growth rate?
Immuneering Corporation has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Immuneering Corporation has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Immuneering Corporation are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IMRX at this time, as Immuneering Corporation has no recent EPS data to calculate it.
